These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man. Vance ML; Kaiser DL; Frohman LA; Rivier J; Vale WW; Thorner MO J Clin Endocrinol Metab; 1987 Jun; 64(6):1136-41. PubMed ID: 3553220 [TBL] [Abstract][Full Text] [Related]
30. Treatment with octreotide and bromocriptine in patients with acromegaly: an open pharmacodynamic interaction study. Fredstorp L; Kutz K; Werner S Clin Endocrinol (Oxf); 1994 Jul; 41(1):103-8. PubMed ID: 8050122 [TBL] [Abstract][Full Text] [Related]
31. Association of the D2 dopamine receptor A1 allele with alcoholism: medical severity of alcoholism and type of controls. Lawford BR; Young RM; Rowell JA; Gibson JN; Feeney GF; Ritchie TL; Syndulko K; Noble EP Biol Psychiatry; 1997 Feb; 41(4):386-93. PubMed ID: 9034533 [TBL] [Abstract][Full Text] [Related]
32. Persistence of defective serotonergic and GABAergic controls of growth hormone secretion in long-term abstinent alcoholics. Vescovi PP; Coiro V Alcohol Alcohol; 1997; 32(1):85-90. PubMed ID: 9131896 [TBL] [Abstract][Full Text] [Related]
34. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Ehrenreich H; Schuck J; Stender N; Pilz J; Gefeller O; Schilling L; Poser W; Kaw S Alcohol Clin Exp Res; 1997 Oct; 21(7):1285-93. PubMed ID: 9347091 [TBL] [Abstract][Full Text] [Related]
35. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression. Trouillas J; Chevallier P; Remy C; Rajas F; Cohen R; Calle A; Hooghe-Peters EL; Rousset B Endocrinology; 1999 Jan; 140(1):13-21. PubMed ID: 9886801 [TBL] [Abstract][Full Text] [Related]
36. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly. Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848 [TBL] [Abstract][Full Text] [Related]
38. Hypothalamic-pituitary-thyroid (HPT) axis in chronic alcoholism. I. HPT axis in chronic alcoholics during withdrawal and after 3 weeks of abstinence. Baumgartner A; Rommelspacher H; Otto M; Schmidt LG; Kürten I; Gräf KJ; Campos-Barros A; Platz W Alcohol Clin Exp Res; 1994 Apr; 18(2):284-94. PubMed ID: 8048729 [TBL] [Abstract][Full Text] [Related]
39. Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor. Jarvis WD; Judd AM; MacLeod RM Endocrinology; 1988 Dec; 123(6):2793-9. PubMed ID: 2904359 [TBL] [Abstract][Full Text] [Related]
40. Growth hormone response to the GABA-B agonist baclofen in 3-week abstinent alcoholics. Ozsoy S; Esel E; Turan T; Kula M Alcohol; 2007 Dec; 41(8):551-6. PubMed ID: 18047908 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]